György Németh

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 336 citations

Predominant Negative Symptoms, Psychiatry, Psychotic Disorder +8

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression

Suresh Durgam, Willie Earley, Alan Lipschitz et al. · American Journal of Psychiatry · 2015 · 202 citations · Full text

Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder

Eduard Vieta, Willie Earley, Maria Victoria Burgess et al. · International Clinical Psychopharmacology · 2018 · 187 citations · Full text

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

Suresh Durgam, Anju Starace, Dayong Li et al. · Schizophrenia Research · 2014 · 174 citations · Full text

Cariprazine in Acute Exacerbation of Schizophrenia

Suresh Durgam, Andrew J. Cutler, Kaifeng Lu et al. · The Journal of Clinical Psychiatry · 2015 · 164 citations · Full text